Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ganesh

Showing results (121-130 of 123) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 123 results.
Journal of Bone Oncology|September 22, 2018
Trends in incidence of Ewing sarcoma of bone in India - Evidence from the National Cancer Registry Programme (1982-2011)Debjit Chakraborty, Sukanya Rangamani, Vaitheeswaran Kulothungan, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
Persistent Immune Dysregulation during Post-Acute Sequelae of COVID-19 is Manifested in Antibodies Targeting Envelope and Nucleocapsid ProteinsMarcin Kwissa, Manikannan Mathayan, Satyajeet S Salunkhe, et al.
Journal of Medicinal Chemistry|March 27, 2014
Discovery of trifluoromethyl(pyrimidin-2-yl)azetidine-2-carboxamides as potent, orally bioavailable TGR5 (GPBAR1) agonists: structure-activity relationships, lead optimization, and chronic in vivo efficacyDean P Phillips, Wenqi Gao, Yang Yang, et al.
Pageof 13

Showing results (121-130 of 123) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 123 results.
Journal of Bone Oncology|September 22, 2018
Trends in incidence of Ewing sarcoma of bone in India - Evidence from the National Cancer Registry Programme (1982-2011)Debjit Chakraborty, Sukanya Rangamani, Vaitheeswaran Kulothungan, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
Persistent Immune Dysregulation during Post-Acute Sequelae of COVID-19 is Manifested in Antibodies Targeting Envelope and Nucleocapsid ProteinsMarcin Kwissa, Manikannan Mathayan, Satyajeet S Salunkhe, et al.
Journal of Medicinal Chemistry|March 27, 2014
Discovery of trifluoromethyl(pyrimidin-2-yl)azetidine-2-carboxamides as potent, orally bioavailable TGR5 (GPBAR1) agonists: structure-activity relationships, lead optimization, and chronic in vivo efficacyDean P Phillips, Wenqi Gao, Yang Yang, et al.
Pageof 13